Heparin Monitoring During Extracorporeal Membrane Oxygenation: the Effect of Dextran Sulfate on Anti-Xa Assay

Overview

Journal Res Pract Thromb Haemost

Publisher Elsevier

Date 2023 Dec 11

PMID 38077812

Authors

Emna Hammami

Laure Stiel

Clement Palpacuer

Ines Harzallah

Affiliations

Soon will be listed here.

Citing Articles

Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical Points.

Gouin-Thibault I, Mansour A, Hardy M, Gueret P, De Maistre E, Siguret V TH Open. 2024; 8(3):e297-e307.

PMID: 39420916 PMC: 11486528. DOI: 10.1055/a-2359-0987.

References

Bland J, Altman D . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476):307-10. View

Derbalah A, Duffull S, Newall F, Moynihan K, Al-Sallami H . Revisiting the Pharmacology of Unfractionated Heparin. Clin Pharmacokinet. 2019; 58(8):1015-1028. DOI: 10.1007/s40262-019-00751-7. View

Gehrie E, Laposata M . Test of the month: The chromogenic antifactor Xa assay. Am J Hematol. 2011; 87(2):194-6. DOI: 10.1002/ajh.22222. View

Smahi M, De Pooter N, Hollestelle M, Toulon P . Monitoring unfractionated heparin therapy: Lack of standardization of anti-Xa activity reagents. J Thromb Haemost. 2020; 18(10):2613-2621. DOI: 10.1111/jth.14969. View

Doyle A, Hunt B . Current Understanding of How Extracorporeal Membrane Oxygenators Activate Haemostasis and Other Blood Components. Front Med (Lausanne). 2019; 5:352. PMC: 6299009. DOI: 10.3389/fmed.2018.00352. View

Hou X . Anticoagulation monitoring in extracorporeal membrane oxygenation. Perfusion. 2021; 36(5):438-439. DOI: 10.1177/02676591211024090. View

Delmas C, Jacquemin A, Vardon-Bounes F, Georges B, Guerrero F, Hernandez N . Anticoagulation Monitoring Under ECMO Support: A Comparative Study Between the Activated Coagulation Time and the Anti-Xa Activity Assay. J Intensive Care Med. 2018; 35(7):679-686. DOI: 10.1177/0885066618776937. View

Levy J, Staudinger T, Steiner M . How to manage anticoagulation during extracorporeal membrane oxygenation. Intensive Care Med. 2022; 48(8):1076-1079. PMC: 9187844. DOI: 10.1007/s00134-022-06723-z. View

McMichael A, Ryerson L, Ratano D, Fan E, Faraoni D, Annich G . 2021 ELSO Adult and Pediatric Anticoagulation Guidelines. ASAIO J. 2022; 68(3):303-310. DOI: 10.1097/MAT.0000000000001652. View

10.

Nunez J, Gosling A, OGara B, Kennedy K, Rycus P, Abrams D . Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis. Intensive Care Med. 2021; 48(2):213-224. PMC: 9178906. DOI: 10.1007/s00134-021-06593-x. View

11.

Mazzeffi M, Clark M, Grazioli A, Dugan C, Rector R, Dalton H . Platelet factor-4 concentration in adult veno-arterial ECMO patients. Perfusion. 2020; 36(7):688-693. DOI: 10.1177/0267659120965104. View